Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
InSite Clinical Resesearch
mi
from
DeSoto, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
InSite Clinical Resesearch
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
InSite Clinical Research LLC
mi
from
DeSoto, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Fein-Jennings Clinic, Inc.
mi
from
Houston, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Fein-Jennings Clinic, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Clinical Trial Network
mi
from
Houston, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Lifetree Clinical Research
mi
from
Salt Lake City, UT
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Birmingham Psychiatry Pharmaceutical Studies, Inc.
mi
from
Birmingham, AL
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Birmingham Psychiatry Pharmaceutical Studies, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Collaborative Neuro Science Network, Inc.
mi
from
Garden Grove, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Collaborative Neuro Science Network, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Stanford -VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Stanford -VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
mi
from
Boston, MA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
mi
from
Boston, MA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Village Clinical Research Inc.
mi
from
New York, NY
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Village Clinical Research Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Psychiatry and Behavioral Sciences, Duke
mi
from
Durham, NC
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Psychiatry and Behavioral Sciences, Duke
mi
from
Durham, NC
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Dept. of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Dept. of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Synergy Clinical Research Center
mi
from
Escondido, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Synergy Clinical Research Center
mi
from
Escondido, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Florida Clinical Research Center, LLC
mi
from
Sarasota, FL
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Florida Clinical Research Center, LLC
mi
from
Sarasota, FL
Click here to add this to my saved trials
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Status: Enrolling
Updated:  3/14/2016
McLean Hospital
mi
from
Belmont, MA
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Status: Enrolling
Updated: 3/14/2016
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Birmingham, AL
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Encino, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Encino, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Escondido, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Escondido, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Garden Grove, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Los Alamitos, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Los Angeles, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Los Angeles, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
National City, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
National City, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Newport Beach, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Oakland, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Oakland, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Oceanside, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Torrance, CA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Jacksonville, FL
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI INvestigational Site
mi
from
Kissimmee, FL
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI INvestigational Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Lauderhill, FL
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Orlando, FL
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Atlanta, GA
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Hoffman Estates, IL
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Towson, MD
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Towson, MD
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Flowood, MS
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Las Vegas, NV
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Marlton, NJ
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated:  3/17/2016
MSI Investigational Site
mi
from
Albuquerque, NM
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy
Status: Enrolling
Updated: 3/17/2016
MSI Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials